Berlin, February 1, 2012 - The Management Board of MagForce AG, a leading medical technology company focusing on nanomedicine in oncology, and its Supervisory Board yesterday approved an increase in the company`s share capital from EUR 4,127,041.00 up to EUR 4,952,449.00 through the partial utilization of its existing authorized capital of up to EUR 825,408.00 newly registered common shares with no par value common with a nominal value of EUR 1.00 per share against cash contributions. The company will offer its shareholders the right to subscribe new shares at a ratio of 5:1 (indirect subscription right). For five `old` shares, one `new` share can be purchased. The subscription period begins for shareholders on Friday, February 3, 2012 and will run for two weeks through February 16, 2012. The subscription price is EUR 5.50. The rights offering for shareholders is expected to be published on Thursday, February 2, 2012 in the electronic Federal Gazette. If all shares are not subscribed, shareholders have the possibility to purchase additional shares to their subscription rights. Unsubscribed shares will first be offered to current shareholders, and any remaining shares will be offered in a  private placement to institutional investors. Major shareholders of MagForce AG have already … Continue reading →

Reporting from Sacramento— A major health insurance company has settled an enforcement action with state regulators over providing special therapy for autism patients. California Insurance Commissioner Dave Jones on Tuesday said that Blue Shield of California Life & Health Insurance Co. agreed to immediately cover the cost of applied behavior analysis therapy, which Jones described as a well-recognized and effective treatment. The settlement with the Insurance Department stems from a dispute that began in July when Jones filed an enforcement action against Blue Shield. "This favorable settlement agreement eliminates the frustration and insecurity so many families have faced when seeking autism treatment for their children," Jones said in a statement. Blue Shield no longer will deny the therapy as a non-covered service, challenge its medical necessity or force parents to get approval from an independent medical reviewer before starting treatment, Jones said. The agreement is similar to one made with the California Department of Managed Health Care in July, said Tom Epstein, Blue Shield's vice president for communications. In fact, Blue Shield in July began paying for the therapy for members enrolled in plans regulated by the Insurance Department, he said. Blue Shield was the first insurer to agree to … Continue reading →

To: HEALTH, MEDICAL AND NATIONAL EDITORS After surgical success, patient gives back through raising awareness and money for epilepsy CHICAGO, Jan. 31, 2012 /PRNewswire-USNewswire/ -- When reflecting back on the most significant day in their life, most people think of their wedding anniversary, or a birthday. For Howard Zwirn, however, January 16, 2004, is a much more important milestone - it's the day the seizures he had experienced for seven years stopped. "That day changed my life and my family's life," said Zwirn. "Since having brain surgery, I've been able to go about my days without constantly worrying when the next seizure might happen. I have my independence back and feel like myself again; for that I am forever grateful." Zwirn experienced his first seizure at the age of 28 while he was sleeping. His wife Jeannine recognized what was occurring and the couple sought help, which ultimately led them to the Comprehensive Epilepsy Center at Northwestern Memorial Hospital. Zwirn was diagnosed with mesial temporal sclerosis, a condition that was causing a type of focal epilepsy and resulting in seizures. Zwirn's seizures continued, taking a toll on his life. Unable to predict when a seizure might occur, he was no … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets(http://www.researchandmarkets.com/research/72568a/blood_pressure_man) has announced the addition of the "Blood Pressure Management and Stroke: Visual Guide for Clinicians" book to their offering. In patients with a history of stroke or TIAs, blood pressure lowering markedly reduces the incidence of stroke recurrence. This guide provides a visual overview of the basic concepts clinicians managing patients with hypertension should understand about ischemic stroke. This includes an in-depth assessment of the relationship between treatment of hypertension and primary and secondary stroke prevention. This title will be a useful reference for doctors treating hypertension in hospital and primary care. Readership: Specialists in hypertension, nephrologists, general physicians, primary care doctors Benefits: Instructive exploration of diagnosis and management of disease to aid practising clinicians and trainee doctors Topic-focused, highly illustrated with succint text - provides collection of original images for clinician's desktop Enables doctors managing hypertensive patients at risk of stroke to define suitable management plan. Key Topics Covered: 1. Stroke basics Isaac Silverman, Marilyn Rymer 2. The Management of acute ischemic stroke and secondary stroke prevention Isaac Silverman, Marilyn Rymer 3. Hypertension as a risk factor for stroke Luis Ruilope Author: Isaac Silverman, Stroke Center, Hartford Hospital, Connecticut, USA; Marilyn Rymer, Mid-America Brain … Continue reading →